RFC2 and cancer: Therefore, in this study, we aimed to investigate RFC2 expression levels and their associations with the clinicopathological parameters and prognosis in LGG and other different types of cancer by using various databases, including Oncomine, The Cancer Genome Atlas (TCGA), Genotype-tissue expression (GTEx), Tumor Immune Estimation Resource (TIMER), Gene Expression Profiling Interactive Analysis (GEPIA), and Human Protein Atlas (HPA).